Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Early Myelodysplastic Changes Present in Substantial Proportion of Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Patients

Neha Korde, MD, Qing Yan Liu, MD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Olga Simakova, PhD, Sham Mailankody, Mark Roschewski, MD, Adriana Zingone, MD, PhD, Rene Costello, Diamond Zuchlinski, RN, Marcia Mulquin, RN, Katherine R Calvo, MD, PhD, Raul C. Braylan, MD, Irina Maric, MD, Ola Landgren, M.D., Ph.D.

Blood (2012) 120 (21): 1805.

https://doi.org/10.1182/blood.V120.21.1805.1805

Published: 2012

Journal Articles

Elevated Risk of Venous but Not Arterial Thrombosis in Waldenström's Macroglobulinemia and Lymphoplasmacytic Lymphoma

Malin L Hultcrantz, MD, Ruth M Pfeiffer, PhD, Magnus Bjorkholm, Lynn Goldin, PhD, Ingemar Turesson, MD, PhD, Sam Schulman, MD, PhD, Ola Landgren, M.D., Ph.D., Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2012) 120 (21): 1603.

https://doi.org/10.1182/blood.V120.21.1603.1603

Published: 2012

Journal Articles

Altered Plasma Cell Characteristics in Smoldering Myeloma and MGUS Patients with Preceding Immune-Related Conditions

Mary L Kwok, MD, Neha Korde, MD, Elisabet E. Manasanch, MD, Aaron W. Flanders, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Adriana Zingone, MD, PhD, Rene Costello, MS, Daniel Cordaro, MD, Audrey Sato, MD, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Mark Roschewski, MD, Ola Landgren, M.D., Ph.D.

Blood (2012) 120 (21): 4006.

https://doi.org/10.1182/blood.V120.21.4006.4006

Published: 2012

Journal Articles

Over 30% of Smoldering Myeloma Patients Have Tumor Cell Bone Marrow Infiltration Patterns Similar to Multiple Myeloma: A Large (n=544) Clinical Study Using Whole-Body MRI.

Jens Hillengass, MD, Kerstin Kilk, MD, Karin Listl, Thomas Hielscher, Kai Neben, MD, Dirk Hose, MD, PhD, Marc-André Weber, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Ola Landgren, M.D., Ph.D.

Blood (2012) 120 (21): 2911.

https://doi.org/10.1182/blood.V120.21.2911.2911

Published: 2012

Journal Articles

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Blood (2012) 120 (21): 732.

https://doi.org/10.1182/blood.V120.21.732.732

Published: 2012

Journal Articles

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Ola Landgren, M.D., Ph.D., Magnus Björkholm, MD, PhD, Malin L Hultcrantz, MD, Christian Kjellander, MD, Ingemar Turesson, MD, PhD, Erik Holmberg, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2012) 120 (21): 945.

https://doi.org/10.1182/blood.V120.21.945.945

Published: 2012

Journal Articles

Appearance of Monoclonal Plasma Cell Diseases in Whole Body MRI in 544 Patients and Correlation with Parameters of Disease Activity

Jens Hillengass, MD, Kerstin Kilk, MD, Karin Listl, Thomas Hielscher, Kai Neben, MD, Dirk Hose, MD, PhD, Anthony D. Ho, MD, Marc-André Weber, MD, Ola Landgren, M.D., Ph.D., Hartmut Goldschmidt, MD

Blood (2012) 120 (21): 4966.

https://doi.org/10.1182/blood.V120.21.4966.4966

Published: 2012

Journal Articles

Let-7 Microrna Family Members Regulate Cell Proliferation in Multiple Myeloma

Salomon Manier, MD, Antonio Sacco, BS, Patricia Maiso, PhD, Yong Zhang, PhD, Yang Liu, PhD, Yosra Aljawai, BS, Weixin Wang, PhD, Meghan Corrigan-Cummins, Xavier Leleu, MD, PhD, Katherine R. Calvo, MD, PhD, Ola Landgren, M.D., Ph.D., Aldo M. Roccaro, MD, PhD, Irene Ghobrial, MD

Blood (2012) 120 (21): 570.

https://doi.org/10.1182/blood.V120.21.570.570

Published: 2012

Journal Articles

Peripheral Blood Involvement with Minimal Disease Is Common in Multiple Myeloma but Not in Smoldering Myeloma

Prashant Ramesh Tembhare, MD, Constance Yuan, MD, PhD, Neha Korde, MD, Elisabet E. Manasanch, MD, Mary Kwok, MD, Mark Roschewski, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Ola Landgren, M.D., Ph.D., Maryalice Stetler-Stevenson, MD, PhD

Blood (2012) 120 (21): 4994.

https://doi.org/10.1182/blood.V120.21.4994.4994

Published: 2012

Journal Articles

Individualized Multidrug Resistance In Acute Myeloid Leukemia

Chirayu Patel, Jean-Pierre Gillet, Leif Stenke, MD, PhD, Marita Lindberg, Magnus Bjorkholm, Jan Sjoberg, Kristina Viktorsson, Rolf Lewensohn, Ola Landgren, M.D., Ph.D., Michael M Gottesman

Blood (2010) 116 (21): 2491.

https://doi.org/10.1182/blood.V116.21.2491.2491

Published: 2010

Journal Articles

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

Malin Hultcrantz, Sigurdur Y. Kristinsson, MD, PhD, Therese M-L Andersson, Sandra Eloranta, Åsa Rangert Derolf, Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm

Blood (2010) 116 (21): 3071.

https://doi.org/10.1182/blood.V116.21.3071.3071

Published: 2010

Journal Articles

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Jerry Katzmann, PhD, Raynell Clark, Angela Dispenzieri, M.D., Robert Kyle, MD, Ola Landgren, M.D., Ph.D., Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD

Blood (2009) 114 (22): 1788.

https://doi.org/10.1182/blood.V114.22.1788.1788

Published: 2009

Journal Articles

Improved Patient Survival and Cure for Hodgkin Lymphoma: A Population-Based Study of 6,136 Patients Diagnosed in Sweden 1973-2005.

Jan Sjoberg, MD, PhD, Cat Halthur, Sigurdur Y Kristinsson, M.D., Ph.D., Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm, MD, PhD

Blood (2009) 114 (22): 1553.

https://doi.org/10.1182/blood.V114.22.1553.1553

Published: 2009

Journal Articles

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.

Åsa Rangert Derolf, M.D., Therese M-L Andersson, Paul C Lambert, Sigurdur Y Kristinsson, M.D., PhD., Sandra Eloranta, Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm, MD, PhD

Blood (2009) 114 (22): 1378.

https://doi.org/10.1182/blood.V114.22.1378.1378

Published: 2009

Journal Articles

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Sigurdur Y Kristinsson, M.D., Ph.D., Ruth Pfeiffer, PhD, Magnus Bjorkholm, MD, PhD, Lynn R Goldin, PhD, Sam Schulman, MD, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2009) 114 (22): 1872.

https://doi.org/10.1182/blood.V114.22.1872.1872

Published: 2009

Journal Articles

Germline Genes Specific to Chronic Lymphocytic Leukemia (CLL) and Genes Common to CLL, Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia, and Other Non-Hodgkin Lymphomas Are Important in Susceptibility

Ola Landgren, M.D., Ph.D., Sigurdur Y Kristinsson, M.D., Xueying Sharon Liang, M.D., Ph.D., Ingemar Turesson, M.D., Ph.D., Magnus Bjorkholm, M.D., Ph.D., Neil E. Caporaso, M.D., Mary L. McMaster, M.D., Stephen Chanock, M.D., Lynn R. Goldin, Ph.D.

Blood (2008) 112 (11): 3127.

https://doi.org/10.1182/blood.V112.11.3127.3127

Published: 2008

Journal Articles

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Sigurdur Y Kristinsson, M.D., Magnus Bjorkholm, MD, PhD, Lynn R. Goldin, Ph.D., Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2008) 112 (11): 1678.

https://doi.org/10.1182/blood.V112.11.1678.1678

Published: 2008

Journal Articles

Immune-Related and Inflammatory Conditions Likely Play a Role in the Development of Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia

Sigurdur Y Kristinsson, M.D., Magnus Bjorkholm, MD, PhD, Jill Koshiol, MD, PhD, Lynn R. Goldin, Ph.D., Mary L. McMaster, M.D., Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2008) 112 (11): 3758.

https://doi.org/10.1182/blood.V112.11.3758.3758

Published: 2008

NARROW

Early Myelodysplastic Changes Present in Substantial Proportion of Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Patients

Elevated Risk of Venous but Not Arterial Thrombosis in Waldenström's Macroglobulinemia and Lymphoplasmacytic Lymphoma

Altered Plasma Cell Characteristics in Smoldering Myeloma and MGUS Patients with Preceding Immune-Related Conditions

Over 30% of Smoldering Myeloma Patients Have Tumor Cell Bone Marrow Infiltration Patterns Similar to Multiple Myeloma: A Large (n=544) Clinical Study Using Whole-Body MRI.

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Appearance of Monoclonal Plasma Cell Diseases in Whole Body MRI in 544 Patients and Correlation with Parameters of Disease Activity

Let-7 Microrna Family Members Regulate Cell Proliferation in Multiple Myeloma

Peripheral Blood Involvement with Minimal Disease Is Common in Multiple Myeloma but Not in Smoldering Myeloma

Individualized Multidrug Resistance In Acute Myeloid Leukemia

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Improved Patient Survival and Cure for Hodgkin Lymphoma: A Population-Based Study of 6,136 Patients Diagnosed in Sweden 1973-2005.

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Germline Genes Specific to Chronic Lymphocytic Leukemia (CLL) and Genes Common to CLL, Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia, and Other Non-Hodgkin Lymphomas Are Important in Susceptibility

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Immune-Related and Inflammatory Conditions Likely Play a Role in the Development of Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only